secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aclarion, Inc. (ACON)
CIK:        0001635077
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001683168-26-000241
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aclarion closes $10.4M equity offering, reports $21.6M cash, zero debt, runway into 2028
--------------------------------------------------------------------------------

- Closed $10.4M common-stock-only offering at $5.18/share; includes 200,000 shares and pre-funded warrants for 1.8M shares.
- Cash balance $21.6M as of Jan 12, 2026; zero debt.
- Cash runway extended into 2028 based on current operating plans.
- Plans to accelerate CLARITY trial enrollment, launch Nociscan v2.8 in Q1'26, and pursue payer coverage.
- Dawson James Securities acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/0001683168-26-000241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1635077/000168316826000241/aclarion_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer